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Background: Children who were treated for leukemia are
known to have developed long term impairment of lung function.
The reasons that complication are only partially known. The aim
of this study was to asses pulmonary function in children treated
due to leukaemia in the past, and indentify risk factors and clinical
manifestations for the impairment of pulmonary function test
(PFT).
Method: 74 survivors of childhood leukaemia: 46 treated with
chemotherapy (HSCT‐), 28 with chemotherapy and haematopoietic
stem cell transplantation (HSCT+), 42 healthy subjects (control group
CG) were evaluated. Spirometry and Diffusion Limit of Carbon
Monoxide (DLCO) tests were performed in all subjects.
Results: The mean values of FEV1, FVC, FEV1/FVC were not sig-
nificantly different in survivors vs CG. 47(66%) patients had reduced
DLCO, 10(14%) restrictive, 5(7%) obstructive pattern. The mean val-
ues of the DLCO were lower in survivors than in CG (P < 0.03), and
in the HSCT+than in the HSCT‐ group (P < 0.05). The pulmonary
infection increased the risk of diffusion impairment OR 5.1 CI (1.16‐
22.9) P = 0.019. DLCO was reduced in patients after CMV pneumo-
nia (P < 0.001). The main symptom of impaired lung diffusion was
poor tolerance of exercise (P < 0.005).
Conclusion: The lower DLCO is the most frequent abnormality in
childhood leukemic survivors. HSCT and pulmonary infection (in par-
ticular CMV pneumonia) is a strong risk factor for impairment of
DLCO in children. Clinical manifestation of DLCO impairment is poor
exercise tolerance. A screening for respiratory abnormalities in sur-
vivors following treatment for childhood haematologic malignancies,
seems to be of significant importance.
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Background: The aims of this study were to identify distinct
classes (phenotypes) of adults with allergic respiratory diseases, using
an unsupervised method, and to examine their associations with
inflammatory biomarkers, and allergic sensitization.
Method: Analysis of all adult participants (n = 728) in the Por-
tuguese nationwide and cross‐sectional study ICAR (Control and
Burden of Asthma and Rhinitis‐PTDC/SAU‐SAP/119192/2010). The
structured medical interview included data on respiratory symptoms,
healthcare usage, and current medication. Measurements of blood
eosinophils (B‐Eos), serum IgE, fractional exhaled nitric oxide (FeNO)
and skin prick test were performed (testing 6 groups of allergens:
mites, dog and cat epitheliums, tree, grass and weed pollens mixtures
and molds). Latent class analysis (LCA) was applied using 16 different
clinical variables on upper/lower airways symptoms and activity limi-
tations/impairment. Associations of LCA classes with biomarkers and
sensitization were examined by multinomial logistic regression,
adjusted for co‐variables.
Results: A four‐class model was obtained: Class 1—”Upper & lower
airways symptoms with limitations” (UA&LAwL) (n = 110;15%), Class
2‐”Upper airways symptoms with impairment” (UAwI) (n = 135;19%),
Class 3‐”Upper symptoms without impairment” (UAsI) (n = 240;33%),
and Class 4‐”No/minimal symptoms” (n = 241;33%). Higher values of
B‐Eos, IgE, FeNO, and number of sensitizations were strong and posi-
tively associated with UA&LAwL, when comparing to any other class.
Distribution of the number of allergen groups in all sample and strati-
fied by LCA classes is presented in table 1. Being sensitized to ≥3
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allergen groups was significantly associated to UAwI (aOR[95%
CI]:2.1[1.3‐3.6]), compared to UAsI.
Conclusion: With an unsupervised cluster analysis, we identified
four phenotypes of allergic respiratory diseases in the Portuguese
general population, that are similar to clinical diagnosis. Being poly-
sensitized to a high number of allergen groups was associated with
multimorbidity (UA&LAwL) and severity (UAwI versus UAsI), war-
ranting further investigation. Moreover, the number of allergen sen-







UA&LAwL, n (%) 16 (14) 28 (26) 66 (60)
UAwI, n (%) 46 (34) 24 (18) 65 (48)
UAsI, n (%) 95 (40) 74 (31) 69 (29)
No/minimal
symptoms, n (%)
134 (56) 54 (23) 51 (21)
Total, n (%) 291 (40) 180 (25) 251 (35)
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Background: Allergic Rhinitis (AR) is one of the most common
chronic diseases, and frequently not recognized by patients who do
not seek medical attention. Pharmacists are generally the first to
attend these patients. Allergic Rhinitis and its Impact on Asthma (ARIA)
establishes evidence‐based standards of best practice for the manage-
ment of patients with AR and their comorbidities.
Objective: To evaluate and compare the level of knowledge about
AR and recommendations of ARIA guidelines among pharmacists in
Brazil (BR) and Paraguay (PY).
Method: 205 pharmacists (BR:78, PR:127) answered the self‐
applicable online questionnaire, (ARIA One Airways questionnaires *
questions about personal and professional data and knowledge
about AR, and ARIA guidelines) using the Google Forms tool.
Results: 80.8% of BR and 49% of PY were women, median age
was 32 years, 35% BR and 52% PY reported having more than four
years of training. Although they recognized the main symptoms of
AR, 26% BR and 100% PY never asked whether the patient had a
medical diagnosis of AR; 20.5% BR and 100.0% PY did not ask
whether the symptoms occurred when close to animals or allergens;
55% BR and 76% of PY did not ask if the patient had a medical
diagnosis of asthma; 59% BR and 70% PY did not ask if rhinitis
worsens asthma symptoms and 51.3% BR and 84.3% PY did not ask
whether symptoms of rhinitis interfere with their daily activities.
Regarding treatment, 34.6% BR and 26.8% PY pharmacist still rec-
ommend first‐generation antihistamines, 59% BR and 52% PY use
nasal topical corticosteroids.
94.9% BR and 60.6% PY would refer the patient to a specialist but
85% BR and 100% PY are unaware of the ARIA Guidelines.
Conclusion: Although pharmacists are the first professionals
sought by the AR patient for symptom relief their level of knowledge
about AR and ARIA Guidelines is very low and do not follow best
clinical recommendations. Training of these professional would allow
the most appropriate advice for the patients they attend.
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Background: Allergic Rhinitis (AR) is a high prevalence chronic dis-
ease, which starts in childhood and persists throughout life. It limits
work productivity and causes absenteeism at school. Allergic Rhinitis
and its Impact on Asthma (ARIA)* establishes evidence‐based stan-
dards of best practice for the management of patients with AR and
its comorbidities.
Objective: To evaluate and compare the level of knowledge about
AR and recommendations of ARIA guide among Primary Care Physi-
cians (PCP) in Brazil (BR), Paraguay (PY) and Uruguay (UY).
Method: 336 PCP (BR: 109, PY: 127, UY: 100) answered the self‐
applicable online questionnaire (ARIA One Airways questionnaires) with
questions about personal and professional data and knowledge about
AR, and the ARIA guideline using the Google Forms tool.
Results: There was a predominance of female (BR: 73%, PY 50.4%,
UY: 70%) median age 31 years old, 124/235 worked in the commu-
nity and 75/127 in the emergency departments, 34% of the BR had
more than 10 years of education, 67% from PY had between 1 and
5 years, and 82% from UY had been graduated for less than 1 year.
BR/UY recognize the main symptoms of AR, however 67% of those
from Uy do not ask: if the patient has physician diagnosis of AR,
72% present shortness of breath, and 93% a medical diagnosis of
asthma, 94% if rhinitis worsens asthma symptoms and 90% if symp-
toms of rhinitis interfere with the patient's daily activities. The pre-
scribed treatment varied a lot, the intranasal corticosteroid use rate
was: BD: 78%, PD: 92% and UD: 54%.
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